Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
05/22/2003 | US20030096357 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/22/2003 | US20030096356 G protein-coupled receptor protein for use in the diagnosis and treatment of alzheimer's disease |
05/22/2003 | US20030096352 Nucleotide sequences coding polypeptides for use in the treatment and prevention of viral and bacterial disease |
05/22/2003 | US20030096351 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/22/2003 | US20030096349 N4 virion single-stranded DNA dependent RNA polymerase |
05/22/2003 | US20030096348 DNA molecules encoding mammalian nuclear receptor protein, nNR5 |
05/22/2003 | US20030096346 Nucleic acids, proteins, and antibodies |
05/22/2003 | US20030096340 Nucleotide sequences coding polypeptide for use in the treatment, diagnosi and prevention of skin, kidney and cell proliferative disorders |
05/22/2003 | US20030096338 Protein conjugate for use in the treatment of blood disorder |
05/22/2003 | US20030096335 Nucleic acid fragment and vector comprising a halogenase, and a process for halogenating chemical compounds |
05/22/2003 | US20030096323 Detecting phosphodiesterase inhibitor; obtain cell, incubate with modulator, monitor expression of cyclic adenine and guanine monophosphates, compare to control, reduction in concentrations indicate inhibitor |
05/22/2003 | US20030096322 System for cell-based screening |
05/22/2003 | US20030096314 Propagation of dendritic cells in culture; obtain pluripotent cells, inoculate nutrient broth, propagate and recover mature dendritic cells |
05/22/2003 | US20030096313 Novel serine-threonine kinase-4 |
05/22/2003 | US20030096312 Novel natrium-calcium exchanger protein |
05/22/2003 | US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof |
05/22/2003 | US20030096296 Detect compound which binds to bone morphogenic protein receptors; obtain sample, incubate with binding agent, allow binding, detect complex formation between binding agent and receptors |
05/22/2003 | US20030096282 Gtpase-activating protein 1 |
05/22/2003 | US20030096279 Nuccleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
05/22/2003 | US20030096269 Method for detecting genomic destabilization arising during tissue culture of plant cells |
05/22/2003 | US20030096267 Essential bacterial genes and their use |
05/22/2003 | US20030096250 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infection of mammals |
05/22/2003 | US20030096234 Monitoring preferential gene expression profile; obtain cellsample, incubate with modulator, monitor gene expression profile, compare to control, evaluate gene expression |
05/22/2003 | US20030096233 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/22/2003 | US20030096221 Methods of identifying g-couple receptors associated with macrophage-thophic hiv, and diagnostic and therapeutic uses thereof |
05/22/2003 | US20030096219 Nucleotide sequence coding polypeptide for use in the treatment of respiratory system disorders |
05/22/2003 | US20030096016 Methods of kidney transplantation utilizing developing nephric tissue |
05/22/2003 | US20030095997 Preferably collagen; capable of promoting formation of granulation tissue, angiogenesis, vascularization and epithelization; useful in surgical suturing. |
05/22/2003 | US20030095989 Chimeric cytolytic viruses for cancer treatment |
05/22/2003 | US20030095986 Production of a parvovirus vaccine in plants as viral coat protein fusions |
05/22/2003 | US20030095973 Chlamydia antigens and corresponding DNA fragments and uses thereof |
05/22/2003 | US20030095968 Viral encoded semaphorin protein receptor DNA and polypeptides |
05/22/2003 | US20030095964 Process for producing humanized chimera antibody |
05/22/2003 | US20030095963 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma |
05/22/2003 | US20030095962 Chimeric cell-surface receptors that undergo antigen-induced association |
05/22/2003 | US20030095960 Three human transferases, polynucleotides that identify and encode them, expression vectors, host cells, antibodies, agonists, and antagonists. |
05/22/2003 | US20030095957 Activation of dendritic cells to enhance immunity |
05/22/2003 | US20030095956 Methods of proliferating undifferentiated neural cells |
05/22/2003 | US20030095955 Provide a balanced selective pressure against emergence of tumor cell variants that would otherwise escape immune detection. |
05/22/2003 | US20030095954 Growth factor gene fused with secretory signal sequence is introduced into fibroblasts ex-vivo using adenovirus vector; infecting cultured non-hematocytes with the vector; administering the cells |
05/22/2003 | US20030095952 Multi-organ engraftment with a single bone marrow-derived stem cell |
05/22/2003 | US20030095947 Compositions and methods for elimination of unwanted cells |
05/22/2003 | CA2784450A1 Polypeptides of pseudomonas aeruginosa |
05/22/2003 | CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
05/22/2003 | CA2472019A1 Production of cell suspensions |
05/22/2003 | CA2468171A1 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
05/22/2003 | CA2467433A1 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
05/22/2003 | CA2467347A1 Histamine receptor h3 polynucleotides |
05/22/2003 | CA2467258A1 Agent for inducing embryonic stem cell to ectodermal cell, method for obtaining the same and use of the same. |
05/22/2003 | CA2466992A1 Apparatus for culturing organism and method of culturing organism |
05/22/2003 | CA2466878A1 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells |
05/22/2003 | CA2466769A1 Methods of expressing lim mineralization protein in non-osseous cells |
05/22/2003 | CA2466521A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
05/22/2003 | CA2466420A1 A novel saitohin gene and uses of same |
05/22/2003 | CA2466415A1 Pgc-1.beta., a novel pgc-1 homologue and uses therefor |
05/22/2003 | CA2466043A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
05/22/2003 | CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
05/22/2003 | CA2464942A1 Signal system and elements used therein |
05/22/2003 | CA2463639A1 Growth hormone variations in humans and their uses |
05/22/2003 | CA2460959A1 Enzymes |
05/22/2003 | CA2454031A1 Novel chromophores/fluorophores and methods for using the same |
05/21/2003 | EP1312679A1 Recombinant MVA virus, and the use thereof |
05/21/2003 | EP1312678A1 Recombinant MVA virus, and the use thereof |
05/21/2003 | EP1312672A1 Method of accumulating foreign gene product in plant seed at high level |
05/21/2003 | EP1312670A1 Method of extensive culture of antigen-specific cytotoxic t cells |
05/21/2003 | EP1312669A1 Cultured epidermal cell sheet, laminated cultured skin sheet and process for producing the same |
05/21/2003 | EP1312668A1 Stem cell culture medium and culture method by using the same |
05/21/2003 | EP1312259A1 Type iii allergic inflammation model animal |
05/21/2003 | EP1311708A1 Method for identifying substances useful for treating inflammation using the response element to the ikappabaplha ror receptor |
05/21/2003 | EP1311696A2 Methods for stable transformation of plants |
05/21/2003 | EP1311694A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
05/21/2003 | EP1311692A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
05/21/2003 | EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
05/21/2003 | EP1311684A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
05/21/2003 | EP1311681A2 Nucleic acids compositions conferring dwarfing phenotype |
05/21/2003 | EP1311680A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
05/21/2003 | EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
05/21/2003 | EP1311678A2 Cripto tumour polypeptide |
05/21/2003 | EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor |
05/21/2003 | EP1311674A2 Compositions and methods for the diagnosis and treatment of tumor |
05/21/2003 | EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
05/21/2003 | EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor |
05/21/2003 | EP1311667A2 Transgenic animal model for neurodegerative disease and uses thereof |
05/21/2003 | EP1311666A2 Progression suppressed gene 13 (psgen 13) and uses thereof |
05/21/2003 | EP1311665A2 Kidney-specific protein |
05/21/2003 | EP1311664A2 Microtubule-associated proteins and tubulins |
05/21/2003 | EP1311663A2 Claudin polypeptides |
05/21/2003 | EP1311658A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
05/21/2003 | EP1311657A2 Tissue engineering scaffolds promoting matrix protein production |
05/21/2003 | EP1311656A1 Use of bioactive glass compositions to stimulate osteoblast production |
05/21/2003 | EP1311547A2 Diagnosis and treatment of cardiovascular conditions |
05/21/2003 | EP1311539A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
05/21/2003 | EP1311537A2 Identification of a cam-kinase ii inhibitor |
05/21/2003 | EP1311529A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
05/21/2003 | EP1311511A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
05/21/2003 | EP1311163A2 Improved insecticidal bacteria, and methods for making and using them |
05/21/2003 | EP1311162A2 Bacillus thurigiensis crystal protein hybrids |
05/21/2003 | EP1311153A2 High temperature cryogenic preservation of biologically active material |
05/21/2003 | EP1248640A4 Preparation and xenotransplantation of porcine islets |
05/21/2003 | EP1042453A4 Biomaterial derived from follicle basement membranes |